Your browser is no longer supported. Please, upgrade your browser.
Settings
QDEL Quidel Corporation daily Stock Chart
QDEL [NASD]
Quidel Corporation
Index- P/E76.61 EPS (ttm)2.05 Insider Own8.80% Shs Outstand42.06M Perf Week-6.18%
Market Cap6.30B Forward P/E21.10 EPS next Y7.44 Insider Trans-5.75% Shs Float37.07M Perf Month11.12%
Income88.30M PEG10.64 EPS next Q1.16 Inst Own89.00% Short Float5.69% Perf Quarter93.55%
Sales561.60M P/S11.21 EPS this Y-0.50% Inst Trans-2.99% Short Ratio2.32 Perf Half Y131.64%
Book/sh14.39 P/B10.90 EPS next Y3.08% ROA9.80% Target Price100.33 Perf Year163.11%
Cash/sh2.71 P/C57.87 EPS next 5Y7.20% ROE16.00% 52W Range52.49 - 210.81 Perf YTD109.10%
Dividend- P/FCF46.74 EPS past 5Y59.90% ROI15.20% 52W High-25.58% Beta1.10
Dividend %- Quick Ratio1.70 Sales past 5Y23.80% Gross Margin61.40% 52W Low198.90% ATR12.29
Employees1250 Current Ratio2.10 Sales Q/Q18.00% Oper. Margin20.00% RSI (14)48.70 Volatility4.53% 7.85%
OptionableYes Debt/Eq0.02 EPS Q/Q55.20% Profit Margin15.70% Rel Volume0.69 Prev Close159.88
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout0.00% Avg Volume910.76K Price156.89
Recom2.30 SMA20-9.86% SMA5015.59% SMA20081.77% Volume628,581 Change-1.87%
May-12-20Downgrade JP Morgan Neutral → Underweight $120 → $158
Mar-26-20Downgrade Barclays Overweight → Equal Weight $90
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Mar-03-11Downgrade Wedbush Outperform → Neutral $14 → $13
Jun-04-20 10:00AM  
Jun-02-20 12:45PM  
Jun-01-20 02:34PM  
09:50AM  
May-29-20 10:34AM  
08:33AM  
07:50AM  
May-28-20 07:53AM  
May-27-20 11:12AM  
May-26-20 04:10PM  
May-23-20 08:00AM  
May-22-20 12:30PM  
09:45AM  
May-20-20 09:07AM  
08:59AM  
May-19-20 09:42AM  
06:46AM  
May-18-20 08:30PM  
09:43AM  
08:44AM  
May-15-20 03:43PM  
11:48AM  
May-14-20 12:45PM  
May-13-20 11:30AM  
03:19AM  
May-12-20 01:54PM  
01:13PM  
May-11-20 05:40PM  
04:46PM  
04:15PM  
03:24PM  
03:09PM  
01:46PM  
01:05PM  
11:47AM  
10:28AM  
09:59AM  
09:11AM  
08:40AM  
07:38AM  
06:40AM  
May-10-20 12:13PM  
04:09AM  
May-09-20 04:58PM  
10:53AM  
May-08-20 09:00PM  
May-07-20 02:31AM  
May-06-20 08:05PM  
04:10PM  
May-05-20 11:02AM  
10:19AM  
08:36AM  
May-04-20 03:17PM  
Apr-30-20 08:29AM  
Apr-29-20 05:00PM  
12:34PM  
Apr-24-20 04:01PM  
Apr-22-20 05:00PM  
Apr-21-20 04:10PM  
Apr-14-20 12:45PM  
Apr-05-20 04:29PM  
Mar-31-20 06:06AM  
Mar-26-20 08:23AM  
Mar-25-20 08:45PM  
Mar-24-20 02:30PM  
07:43AM  
06:51AM  
Mar-18-20 01:01PM  
Mar-17-20 08:30PM  
Mar-16-20 11:03AM  
Mar-12-20 11:27AM  
Mar-08-20 10:08AM  
Feb-19-20 10:52PM  
Feb-18-20 04:10PM  
Feb-17-20 07:54AM  
Feb-12-20 06:45PM  
04:10PM  
Feb-05-20 12:30PM  
Jan-28-20 04:10PM  
12:46PM  
Jan-09-20 06:00PM  
12:41PM  
Dec-13-19 11:04AM  
Dec-11-19 12:34PM  
Nov-19-19 11:18AM  
Nov-14-19 06:00PM  
Nov-05-19 09:40AM  
Oct-30-19 08:35PM  
04:10PM  
11:43AM  
Oct-24-19 02:06PM  
Oct-23-19 10:33AM  
Oct-17-19 06:00PM  
Oct-10-19 12:02PM  
Sep-23-19 11:28AM  
Sep-06-19 12:19AM  
Sep-04-19 12:25PM  
Aug-30-19 09:15PM  
Aug-19-19 08:02AM  
Aug-12-19 12:48PM  
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kroll WernerSVP, R&DMay 27Option Exercise0.004,37608,975May 27 07:54 PM
Kroll WernerSVP, R&DMay 22Option Exercise20.4668,1521,394,42272,751May 27 07:54 PM
Kroll WernerSVP, R&DMay 22Sale174.4468,15211,888,1494,599May 27 07:54 PM
Bujarski Robert JosephSVP, NA Comm Ops & Gen CounselMay 20Sale189.4120,0003,788,28213,383May 22 07:59 PM
Abney Michael Donald Jr.SVP - DistributionMay 18Option Exercise17.9515,970286,67515,432May 20 08:02 PM
BORKAR RATAN SSVP, Intl Comm OperationsMay 18Option Exercise31.8816,332520,69927,171May 20 08:07 PM
STEWARD RANDALL JChief Financial OfficerMay 18Sale185.3520,0003,707,0402,848May 20 08:11 PM
BORKAR RATAN SSVP, Intl Comm OperationsMay 18Sale192.8228,3125,459,113524May 20 08:07 PM
Abney Michael Donald Jr.SVP - DistributionMay 18Sale198.4615,9703,169,3876,634May 20 08:02 PM
SLACIK CHARLES PDirectorMay 15Option Exercise0.00549011,352May 18 08:16 PM
BUECHLER KENNETH FDirectorMay 15Option Exercise0.001,842059,824May 18 08:06 PM
WIDDER KENNETH JDirectorMay 14Option Exercise0.002,100014,416May 18 08:21 PM
Strobeck MatthewDirectorMay 14Option Exercise0.002,10007,399May 18 08:19 PM
BUECHLER KENNETH FDirectorMay 14Option Exercise0.002,100057,982May 18 08:06 PM
SLACIK CHARLES PDirectorMay 14Option Exercise0.002,100010,803May 18 08:16 PM
SCHULER JACK WDirectorMay 14Option Exercise0.002,10003,103,249May 18 08:14 PM
POLAN MARY LAKE PH DDirectorMay 14Option Exercise0.002,100022,884May 18 08:12 PM
ORDONEZ KATHYDirectorMay 14Option Exercise0.001,85601,856May 18 08:10 PM
Michael Edward L.DirectorMay 14Option Exercise0.002,10002,934May 18 08:08 PM
POLAN MARY LAKE PH DDirectorMay 11Sale204.276,7001,368,63020,784May 12 08:01 PM
BUECHLER KENNETH FDirectorMay 11Sale200.005,0001,000,00055,882May 13 08:01 PM
BUECHLER KENNETH FDirectorMay 05Option Exercise13.2510,449138,44960,882May 07 08:05 PM
Russell Edward KeithSVP, Business DevelopmentFeb 26Option Exercise15.4012,601194,05529,791Feb 28 08:03 PM
Russell Edward KeithSVP, Business DevelopmentFeb 26Sale79.5812,6011,002,79617,190Feb 28 08:03 PM
POLAN MARY LAKE PH DDirectorJan 07Option Exercise21.079,041190,49428,584Jan 09 08:23 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 06Option Exercise15.6711,122174,22620,426Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 06Sale70.0011,122778,5409,304Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 05Option Exercise23.414,700110,02714,004Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 05Sale70.004,700329,0009,304Dec 09 07:59 PM
Kroll WernerSVP, R&DDec 03Option Exercise22.856,620151,26723,389Dec 05 09:35 PM
Kroll WernerSVP, R&DDec 03Sale68.0222,9511,561,0783,795Dec 05 09:35 PM
Russell Edward KeithSVP, Business DevelopmentNov 26Option Exercise19.5615,974312,43832,452Nov 27 07:47 PM
Russell Edward KeithSVP, Business DevelopmentNov 26Sale68.7315,9741,097,95116,478Nov 27 07:47 PM
BORKAR RATAN SSVP, Intl Comm OperationsNov 26Sale68.406,621452,8859,304Nov 27 07:45 PM
BORKAR RATAN SSVP, Intl Comm OperationsNov 25Sale69.1833222,96915,925Nov 27 07:45 PM
BRYANT DOUGLAS CPresident & CEONov 20Option Exercise22.42377,7448,470,451679,186Nov 22 08:03 PM
STEWARD RANDALL JChief Financial OfficerSep 23Option Exercise15.4029,328451,65148,787Sep 25 07:59 PM
STEWARD RANDALL JChief Financial OfficerSep 23Sale62.6029,3281,836,04119,459Sep 25 07:59 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 13Sale67515.004,527305,640,405759Sep 13 08:01 PM
BORKAR RATAN SSVP, Intl Comm OperationsSep 11Option Exercise27.345,575152,42121,768Sep 13 07:58 PM
BUECHLER KENNETH FDirectorSep 11Option Exercise13.254,00053,00054,433Sep 13 07:59 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 11Option Exercise25.5514,354366,74519,545Sep 13 08:01 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 11Sale68.6114,354984,8805,191Sep 13 08:01 PM
BUECHLER KENNETH FDirectorSep 11Sale68.864,000275,42150,433Sep 13 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsSep 11Sale70.005,575390,25016,257Sep 13 07:58 PM
Abney Michael Donald Jr.SVP - DistributionSep 10Option Exercise15.408,798135,48914,226Sep 12 08:01 PM
Abney Michael Donald Jr.SVP - DistributionSep 10Sale65.008,798571,8705,790Sep 12 08:01 PM
BRYANT DOUGLAS CPresident & CEOAug 30Option Exercise15.195107,747301,952Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 30Sale65.4051033,354301,442Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 29Option Exercise15.1945,948697,950347,390Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 29Sale64.2845,9482,953,400301,442Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 28Option Exercise15.1925,250383,548326,692Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 28Sale58.3025,2501,472,075301,442Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOJul 29Option Exercise15.1921,789330,975323,231Jul 31 08:04 PM
BRYANT DOUGLAS CPresident & CEOJul 29Sale57.7821,7891,258,968301,442Jul 31 08:04 PM
BRYANT DOUGLAS CPresident & CEOJun 28Option Exercise15.193,46152,573304,903Jun 28 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 26Option Exercise14.6025,250368,602326,692Jun 28 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 26Sale57.2525,2501,445,613301,442Jun 28 07:59 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJun 18Option Exercise17.3813,000225,90522,598Jun 20 07:54 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJun 18Sale57.1613,000743,0469,598Jun 20 07:54 PM